- Home
- OMH vs ARTV Comparison
OMH vs ARTV Comparison
Compare OMH & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- ARTV
- Stock Information
- Founded
- OMH 2015
- ARTV 2019
- Country
- OMH Singapore
- ARTV United States
- Employees
- OMH 108
- ARTV N/A
- Industry
- OMH Real Estate
- ARTV
- Sector
- OMH Finance
- ARTV
- Exchange
- OMH Nasdaq
- ARTV NYSE
- Market Cap
- OMH 35.8M
- ARTV 39.0M
- IPO Year
- OMH 2023
- ARTV 2024
- Fundamental
- Price
- OMH $1.47
- ARTV $2.04
- Analyst Decision
- OMH Hold
- ARTV Strong Buy
- Analyst Count
- OMH 1
- ARTV 8
- Target Price
- OMH N/A
- ARTV $18.14
- AVG Volume (30 Days)
- OMH 179.3K
- ARTV 366.6K
- Earning Date
- OMH 07-18-2025
- ARTV 08-28-2025
- Dividend Yield
- OMH N/A
- ARTV N/A
- EPS Growth
- OMH N/A
- ARTV N/A
- EPS
- OMH N/A
- ARTV N/A
- Revenue
- OMH $7,976,578.00
- ARTV N/A
- Revenue This Year
- OMH $28.40
- ARTV N/A
- Revenue Next Year
- OMH $23.07
- ARTV N/A
- P/E Ratio
- OMH N/A
- ARTV N/A
- Revenue Growth
- OMH 117.53
- ARTV N/A
- 52 Week Low
- OMH $0.59
- ARTV $1.47
- 52 Week High
- OMH $6.20
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- OMH 45.64
- ARTV N/A
- Support Level
- OMH $1.32
- ARTV N/A
- Resistance Level
- OMH $1.60
- ARTV N/A
- Average True Range (ATR)
- OMH 0.10
- ARTV 0.00
- MACD
- OMH 0.03
- ARTV 0.00
- Stochastic Oscillator
- OMH 53.07
- ARTV 0.00
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).